Mabion Future Growth
Future criteria checks 1/6
Mabion's revenue is forecast to decline at 0.4% per annum while its annual earnings are expected to grow at 11.8% per year. EPS is expected to decline by 59.1% per annum. Return on equity is forecast to be -11.8% in 3 years.
Key information
11.8%
Earnings growth rate
-59.1%
EPS growth rate
Biotechs earnings growth | 32.3% |
Revenue growth rate | -0.4% |
Future return on equity | -11.8% |
Analyst coverage | Low |
Last updated | 09 Dec 2024 |
Recent future growth updates
Recent updates
Revenues Working Against Mabion S.A.'s (WSE:MAB) Share Price Following 29% Dive
Dec 22Some May Be Optimistic About Mabion's (WSE:MAB) Earnings
Nov 06Investors Don't See Light At End Of Mabion S.A.'s (WSE:MAB) Tunnel And Push Stock Down 30%
Nov 05Mabion's (WSE:MAB) Shareholders May Want To Dig Deeper Than Statutory Profit
Apr 24Mabion S.A. (WSE:MAB) Shares Fly 30% But Investors Aren't Buying For Growth
Nov 28Industry Analysts Just Made A Huge Upgrade To Their Mabion S.A. (WSE:MAB) Revenue Forecasts
Jun 02Does Mabion (WSE:MAB) Have A Healthy Balance Sheet?
Jul 09Mabion (WSE:MAB) Is Posting Solid Earnings, But It Is Not All Good News
Jun 04Is Mabion (WSE:MAB) Using Too Much Debt?
Dec 22Mabion S.A. (WSE:MAB) Shares Could Be 47% Below Their Intrinsic Value Estimate
Sep 11How Much Of Mabion S.A. (WSE:MAB) Do Institutions Own?
Feb 24Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 69 | 3 | -19 | 11 | 2 |
12/31/2026 | 51 | -17 | -17 | -12 | 3 |
12/31/2025 | 24 | -34 | -32 | -27 | 3 |
12/31/2024 | 66 | -3 | 8 | 28 | 3 |
9/30/2024 | 111 | 10 | 15 | 47 | N/A |
6/30/2024 | 140 | 37 | 12 | 55 | N/A |
3/31/2024 | 146 | 42 | -41 | 4 | N/A |
12/31/2023 | 152 | 41 | -40 | -2 | N/A |
9/30/2023 | 148 | 58 | 34 | 62 | N/A |
6/30/2023 | 157 | 42 | 33 | 52 | N/A |
3/31/2023 | 165 | 32 | 69 | 84 | N/A |
12/31/2022 | 164 | 23 | 22 | 39 | N/A |
9/30/2022 | 156 | 45 | -67 | -46 | N/A |
6/30/2022 | 117 | 34 | -52 | -24 | N/A |
3/31/2022 | 75 | 26 | -109 | -75 | N/A |
12/31/2021 | 36 | 2 | -65 | -33 | N/A |
9/30/2021 | 2 | -51 | -38 | -20 | N/A |
6/30/2021 | 2 | -45 | -58 | -49 | N/A |
3/31/2021 | N/A | -53 | -13 | -10 | N/A |
12/31/2020 | N/A | -56 | -39 | -35 | N/A |
9/30/2020 | N/A | -55 | -40 | -35 | N/A |
6/30/2020 | N/A | -63 | -35 | -30 | N/A |
3/31/2020 | N/A | -69 | -37 | -31 | N/A |
12/31/2019 | N/A | -64 | -43 | -34 | N/A |
9/30/2019 | N/A | -65 | -42 | -31 | N/A |
6/30/2019 | N/A | -59 | -36 | -24 | N/A |
3/31/2019 | N/A | -70 | -44 | -34 | N/A |
12/31/2018 | N/A | -69 | -46 | -39 | N/A |
9/30/2018 | N/A | -72 | -48 | -42 | N/A |
6/30/2018 | N/A | -74 | N/A | -62 | N/A |
3/31/2018 | N/A | -59 | N/A | -61 | N/A |
12/31/2017 | N/A | -58 | N/A | -54 | N/A |
9/30/2017 | N/A | -56 | N/A | -35 | N/A |
6/30/2017 | N/A | -57 | N/A | -24 | N/A |
3/31/2017 | N/A | -59 | N/A | -26 | N/A |
12/31/2016 | N/A | -56 | N/A | -15 | N/A |
9/30/2016 | 0 | -77 | N/A | -36 | N/A |
6/30/2016 | 0 | -65 | N/A | -44 | N/A |
3/31/2016 | 3 | -51 | N/A | -30 | N/A |
12/31/2015 | 3 | -43 | N/A | -32 | N/A |
9/30/2015 | 3 | -6 | N/A | -29 | N/A |
6/30/2015 | 3 | -5 | N/A | -24 | N/A |
3/31/2015 | 1 | -5 | N/A | -30 | N/A |
12/31/2014 | 1 | -4 | N/A | -24 | N/A |
9/30/2014 | 1 | -4 | N/A | -20 | N/A |
6/30/2014 | 0 | -4 | N/A | -26 | N/A |
3/31/2014 | 0 | -4 | N/A | -23 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MAB's forecast earnings growth (11.8% per year) is above the savings rate (4.1%).
Earnings vs Market: MAB's earnings (11.8% per year) are forecast to grow slower than the Polish market (16.3% per year).
High Growth Earnings: MAB's earnings are forecast to grow, but not significantly.
Revenue vs Market: MAB's revenue is expected to decline over the next 3 years (-0.4% per year).
High Growth Revenue: MAB's revenue is forecast to decline over the next 3 years (-0.4% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MAB is forecast to be unprofitable in 3 years.
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/31 15:02 |
End of Day Share Price | 2025/01/31 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Mabion S.A. is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Kamil Kliszcz | Biuro maklerskie mBanku |
Beata Szparaga-Wasniewska | Biuro maklerskie mBanku |
Pawel Sugalski | ING Groep NV |